Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): An open-label, phase 3 randomised controlled trial

Hugo E R Ford*, Andrea Marshall, John A. Bridgewater, Tobias Janowitz, Fareeda Y. Coxon, Jonathan Wadsley, Wasat Mansoor, David Fyfe, Srinivasan Madhusudan, Gary W. Middleton, Daniel Swinson, Stephen Falk, Ian Chau, David Cunningham, Paula Kareclas, Natalie Cook, Jane M. Blazeby, Janet A. Dunn

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

387 Citations (Scopus)
239 Downloads (Pure)

Search results